Correlation Between Hepion Pharmaceuticals and Propanc Biopharma

Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hepion Pharmaceuticals and Propanc Biopharma, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Propanc Biopharma.

Diversification Opportunities for Hepion Pharmaceuticals and Propanc Biopharma

0.46

Correlation Coefficient

Hepion Pharmaceuticals  Propanc Biopharma

Very weak diversification

The 3 months correlation between Hepion and Propanc is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Propanc Biopharma go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Propanc Biopharma

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Propanc Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Hepion Pharmaceuticals is 2.76 times less risky than Propanc Biopharma. The stock trades about -0.05 of its potential returns per unit of risk. The Propanc Biopharma is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  35.00  in Propanc Biopharma on October 22, 2024 and sell it today you would lose (34.97) from holding Propanc Biopharma or give up 99.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

Hepion Pharmaceuticals  vs.  Propanc Biopharma

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Propanc Biopharma

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hepion Pharmaceuticals and Propanc Biopharma

The main advantage of trading using opposite Hepion Pharmaceuticals and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.

The idea behind Hepion Pharmaceuticals and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.